Summary
Latest filing:
Matthew Angel is CEO and President of Tempest Therapeutics, Inc. (TPST). 3 SEC Form 4 filings on record, most recently on 23 June 2026. Most recent open-market trade: bought $500K of TPST on 23 June 2026. Lifetime open-market purchases: $1.00M.
Recent Transactions
2Every recent SEC Form 4 transaction Matthew Angel has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Matthew Angel's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GTCR INVESTMENT XI LLC - $639.50M of SHC open-market activity in the last 12 months
- Keith A. Meister - $591.13M of ILMN open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
- Mozart Aggregator II LP - $579.20M of MDLN open-market activity in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M of MDLN open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Matthew Angel?
Matthew Angel is a corporate insider, tracked as CEO and President of Tempest Therapeutics, Inc. (TPST). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matthew Angel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew Angel been buying or selling stock?
Recorded transactions: 4 open-market purchases ($1.00M) and 0 open-market sales across all tracked filings.
Where can I see all of Matthew Angel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Matthew Angel and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
